A proactive genotype-to-patient-phenotype map for cystathionine beta-synthase

0301 basic medicine Saccharomyces cerevisiae Proteins Genotype Clinical Sciences Mutation, Missense 610 Cystathionine beta-Synthase Saccharomyces cerevisiae QH426-470 Medical Genetics and Genomics 03 medical and health sciences Genetics 2.1 Biological and endogenous factors Humans Genetic Testing Aetiology Medicinsk genetik Prevention Research Genetic Complementation Test R Medicinsk genetik och genomik 3. Good health Phenotype Mutation Medicine Homocystinuria Missense Medical Genetics Biotechnology
DOI: 10.1186/s13073-020-0711-1 Publication Date: 2020-01-30T13:03:13Z
ABSTRACT
AbstractBackgroundFor the majority of rare clinical missense variants, pathogenicity status cannot currently be classified. Classical homocystinuria, characterized by elevated homocysteine in plasma and urine, is caused by variants in the cystathionine beta-synthase (CBS) gene, most of which are rare. With early detection, existing therapies are highly effective.MethodsDamagingCBSvariants can be detected based on their failure to restore growth in yeast cells lacking the yeast orthologCYS4. This assay has only been applied reactively, after first observing a variant in patients. Using saturation codon-mutagenesis, en masse growth selection, and sequencing, we generated a comprehensive, proactive map of CBS missense variant function.ResultsOur CBS variant effect map far exceeds the performance of computational predictors of disease variants. Map scores correlated strongly with both disease severity (Spearman’sϱ = 0.9) and human clinical response to vitamin B6(ϱ = 0.93).ConclusionsWe demonstrate that highly multiplexed cell-based assays can yield proactive maps of variant function and patient response to therapy, even for rare variants not previously seen in the clinic.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (72)
CITATIONS (50)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....